CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Open-market buy Director bought 5,000 shares at $7.93 ($39,650)
- 4 Open-market buy Chief Financial Officer bought 4,100 shares at $7.63 ($31,286)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- S-3 Offering Registration Statement
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 4 Open-market buy 10% owner bought 30,684 shares at $13.87 ($425,648)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 34,658 shares at $11.21 ($388,516)
Page 10 of 15 · 292 filings